Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Biotherapeutics Cell Line Development market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Biotherapeutics Cell Line Developmentmarket, defines the market attractiveness level of Biotherapeutics Cell Line Development market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Biotherapeutics Cell Line Development industry, describes the types of Biotherapeutics Cell Line Development market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biotherapeutics Cell Line Development market and the development prospects and opportunities of Biotherapeutics Cell Line Development industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biotherapeutics Cell Line Development market in Chapter 13.
By Player:
Beckman Coulter
Becton Dickinson & Company
Selexis SA
Catalent Inc
CMC Biologics A/S
ProBioGen AG
EMD Millipore
Thermo Fisher Scientific Inc
Partec (Sysmex Corporation)
Sony Biotechnology Inc
Boehringer Ingelheim Group
Lonza Group Ltd
Sigma-Aldrich Co LLC
By Type:
Transfection & Selection
Single Cell Cloning
By End-User:
In-house
Outsource
Hybrid
Do-It-Yourself (DIY)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Biotherapeutics Cell Line Development Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Biotherapeutics Cell Line Development Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Biotherapeutics Cell Line Development Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Biotherapeutics Cell Line Development Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Biotherapeutics Cell Line Development Market Analysis and Outlook to 2022
-
7.1 Global Biotherapeutics Cell Line Development Consumption (2017-2022)
-
7.2 United States Biotherapeutics Cell Line Development Consumption (2017-2022)
-
7.3 Europe Biotherapeutics Cell Line Development Consumption (2017-2022)
-
7.4 China Biotherapeutics Cell Line Development Consumption (2017-2022)
-
7.5 Japan Biotherapeutics Cell Line Development Consumption (2017-2022)
-
7.6 India Biotherapeutics Cell Line Development Consumption (2017-2022)
-
7.7 South Korea Biotherapeutics Cell Line Development Consumption (2017-2022)
8 Region and Country-wise Biotherapeutics Cell Line Development Market Analysis and Outlook to 2028
-
8.1 Global Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
-
8.2 United States Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
-
8.3 Europe Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
-
8.4 China Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
-
8.5 Japan Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
-
8.6 India Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
-
8.7 South Korea Biotherapeutics Cell Line Development Consumption Forecast (2022-2028)
9 Global Biotherapeutics Cell Line Development Market Outlook by Types and Applications to 2022
-
9.1 Global Biotherapeutics Cell Line Development Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Transfection & Selection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Single Cell Cloning Consumption and Growth Rate (2017-2022)
-
9.2 Global Biotherapeutics Cell Line Development Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global In-house Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Outsource Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hybrid Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Do-It-Yourself (DIY) Consumption and Growth Rate (2017-2022)
10 Global Biotherapeutics Cell Line Development Market Outlook by Types and Applications to 2028
-
10.1 Global Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Transfection & Selection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Single Cell Cloning Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global In-house Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Outsource Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hybrid Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Do-It-Yourself (DIY) Consumption Forecast and Growth Rate (2022-2028)
11 Global Biotherapeutics Cell Line Development Import and Export Analysis (Top 5 Countries)
-
11.1 Global Biotherapeutics Cell Line Development Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Biotherapeutics Cell Line Development Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Biotherapeutics Cell Line Development Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Biotherapeutics Cell Line Development Market Competitive Analysis
-
14.1 Beckman Coulter
-
14.1.1 Beckman Coulter Company Details
-
14.1.2 Beckman Coulter Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Beckman Coulter Biotherapeutics Cell Line Development Product and Service
-
14.2 Becton Dickinson & Company
-
14.2.1 Becton Dickinson & Company Company Details
-
14.2.2 Becton Dickinson & Company Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Service
-
14.3 Selexis SA
-
14.3.1 Selexis SA Company Details
-
14.3.2 Selexis SA Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Selexis SA Biotherapeutics Cell Line Development Product and Service
-
14.4 Catalent Inc
-
14.4.1 Catalent Inc Company Details
-
14.4.2 Catalent Inc Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Catalent Inc Biotherapeutics Cell Line Development Product and Service
-
14.5 CMC Biologics A/S
-
14.5.1 CMC Biologics A/S Company Details
-
14.5.2 CMC Biologics A/S Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Product and Service
-
14.6 ProBioGen AG
-
14.6.1 ProBioGen AG Company Details
-
14.6.2 ProBioGen AG Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ProBioGen AG Biotherapeutics Cell Line Development Product and Service
-
14.7 EMD Millipore
-
14.7.1 EMD Millipore Company Details
-
14.7.2 EMD Millipore Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 EMD Millipore Biotherapeutics Cell Line Development Product and Service
-
14.8 Thermo Fisher Scientific Inc
-
14.8.1 Thermo Fisher Scientific Inc Company Details
-
14.8.2 Thermo Fisher Scientific Inc Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Thermo Fisher Scientific Inc Biotherapeutics Cell Line Development Product and Service
-
14.9 Partec (Sysmex Corporation)
-
14.9.1 Partec (Sysmex Corporation) Company Details
-
14.9.2 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Service
-
14.10 Sony Biotechnology Inc
-
14.10.1 Sony Biotechnology Inc Company Details
-
14.10.2 Sony Biotechnology Inc Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sony Biotechnology Inc Biotherapeutics Cell Line Development Product and Service
-
14.11 Boehringer Ingelheim Group
-
14.11.1 Boehringer Ingelheim Group Company Details
-
14.11.2 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Service
-
14.12 Lonza Group Ltd
-
14.12.1 Lonza Group Ltd Company Details
-
14.12.2 Lonza Group Ltd Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Lonza Group Ltd Biotherapeutics Cell Line Development Product and Service
-
14.13 Sigma-Aldrich Co LLC
-
14.13.1 Sigma-Aldrich Co LLC Company Details
-
14.13.2 Sigma-Aldrich Co LLC Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sigma-Aldrich Co LLC Biotherapeutics Cell Line Development Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Biotherapeutics Cell Line Development
-
Figure Biotherapeutics Cell Line Development Picture
-
Table Global Biotherapeutics Cell Line Development Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biotherapeutics Cell Line Development Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biotherapeutics Cell Line Development Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Biotherapeutics Cell Line Development Consumption by Country (2017-2022)
-
Figure United States Biotherapeutics Cell Line Development Consumption and Growth Rate (2017-2022)
-
Table Europe Biotherapeutics Cell Line Development Consumption and Growth Rate (2017-2022)
-
Figure China Biotherapeutics Cell Line Development Consumption and Growth Rate (2017-2022)
-
Figure Japan Biotherapeutics Cell Line Development Consumption and Growth Rate (2017-2022)
-
Figure India Biotherapeutics Cell Line Development Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biotherapeutics Cell Line Development Consumption and Growth Rate (2017-2022)
-
Figure Global Biotherapeutics Cell Line Development Consumption Forecast by Country (2022-2028)
-
Figure United States Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biotherapeutics Cell Line Development Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transfection & Selection Consumption and Growth Rate (2017-2022)
-
Figure Global Single Cell Cloning Consumption and Growth Rate (2017-2022)
-
Figure Global In-house Consumption and Growth Rate (2017-2022)
-
Figure Global Outsource Consumption and Growth Rate (2017-2022)
-
Figure Global Hybrid Consumption and Growth Rate (2017-2022)
-
Figure Global Do-It-Yourself (DIY) Consumption and Growth Rate (2017-2022)
-
Figure Global Transfection & Selection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single Cell Cloning Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In-house Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Outsource Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hybrid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Do-It-Yourself (DIY) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Biotherapeutics Cell Line Development Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Biotherapeutics Cell Line Development Export by Region (Top 5 Countries) (2017-2028)
-
Table Beckman Coulter (Foundation Year, Company Profile and etc.)
-
Table Beckman Coulter Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beckman Coulter Biotherapeutics Cell Line Development Product and Service
-
Table Becton Dickinson & Company (Foundation Year, Company Profile and etc.)
-
Table Becton Dickinson & Company Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Service
-
Table Selexis SA (Foundation Year, Company Profile and etc.)
-
Table Selexis SA Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Selexis SA Biotherapeutics Cell Line Development Product and Service
-
Table Catalent Inc (Foundation Year, Company Profile and etc.)
-
Table Catalent Inc Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalent Inc Biotherapeutics Cell Line Development Product and Service
-
Table CMC Biologics A/S (Foundation Year, Company Profile and etc.)
-
Table CMC Biologics A/S Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table CMC Biologics A/S Biotherapeutics Cell Line Development Product and Service
-
Table ProBioGen AG (Foundation Year, Company Profile and etc.)
-
Table ProBioGen AG Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProBioGen AG Biotherapeutics Cell Line Development Product and Service
-
Table EMD Millipore (Foundation Year, Company Profile and etc.)
-
Table EMD Millipore Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table EMD Millipore Biotherapeutics Cell Line Development Product and Service
-
Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Inc Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc Biotherapeutics Cell Line Development Product and Service
-
Table Partec (Sysmex Corporation) (Foundation Year, Company Profile and etc.)
-
Table Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Service
-
Table Sony Biotechnology Inc (Foundation Year, Company Profile and etc.)
-
Table Sony Biotechnology Inc Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sony Biotechnology Inc Biotherapeutics Cell Line Development Product and Service
-
Table Boehringer Ingelheim Group (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Group Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Service
-
Table Lonza Group Ltd (Foundation Year, Company Profile and etc.)
-
Table Lonza Group Ltd Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Group Ltd Biotherapeutics Cell Line Development Product and Service
-
Table Sigma-Aldrich Co LLC (Foundation Year, Company Profile and etc.)
-
Table Sigma-Aldrich Co LLC Biotherapeutics Cell Line Development Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma-Aldrich Co LLC Biotherapeutics Cell Line Development Product and Service
-
